Stockscreener 앱 받기
1.38
0.73%
0.010
시간 외 거래:
1.40
0.02
+1.45%
전일 마감가:
$1.37
열려 있는:
$1.37
하루 거래량:
169.50K
Relative Volume:
0.13
시가총액:
$23.35M
수익:
-
순이익/손실:
$-11.24M
주가수익비율:
-1.8122
EPS:
-0.7615
순현금흐름:
$-4.79M
1주 성능:
-10.39%
1개월 성능:
+22.12%
6개월 성능:
+20.00%
1년 성능:
-34.91%
1일 변동 폭
$1.35
$1.4078
1주일 범위
$1.35
$1.5898
52주 변동 폭
$0.73
$2.70
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
명칭
Mira Pharmaceuticals Inc
전화
813-369-5150
주소
1200 BRICKELL AVENUE, MIAMI
MIRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.38 | 26.41M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
625.65 | 670.04B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
173.33 | 410.84B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
198.05 | 346.78B | 58.33B | 3.76B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
116.84 | 219.72B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
80.69 | 198.42B | 63.62B | 16.41B | 14.72B | 6.49 |
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
Combining price and volume data for MIRA Pharmaceuticals Inc.Short Term Profit Strategy with Entry Cues - Newser
Real time scanner hits for MIRA Pharmaceuticals Inc. explainedFree Alert Feed for Momentum Based Picks - Newser
MIRA Pharmaceuticals Inc. stock trendline breakdown3-Year Equity Summary With Setup Insights - Newser
Analyzing drawdowns of MIRA Pharmaceuticals Inc. with statistical toolsFree High Win Rate Trading Opportunities - Newser
MIRA Pharmaceuticals Announces Virtual Annual Meeting to Discuss SKNY Merger - MSN
Is it too late to sell MIRA Pharmaceuticals Inc.Pattern Breakout Prediction for Short Term - Newser
How to build a custom watchlist for MIRA Pharmaceuticals Inc.Smart Trend Analysis With Buy Point Cues - Newser
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - The Florida Times-Union
What makes MIRA Pharmaceuticals Inc. stock price move sharplyUncover the best stocks for explosive growth - Jammu Links News
What analysts say about MIRA Pharmaceuticals Inc. stockAchieve rapid returns with smart investment plans - Jammu Links News
When is MIRA Pharmaceuticals Inc. stock expected to show significant growthBuild a strong portfolio for long-term success - Jammu Links News
What are MIRA Pharmaceuticals Inc. company’s key revenue driversExceptional stock performance - Jammu Links News
Is MIRA Pharmaceuticals Inc. stock overvalued or undervaluedInvest confidently with daily market forecasts - Jammu Links News
Published on: 2025-08-03 20:19:04 - Jammu Links News
Is MIRA Pharmaceuticals Inc. a growth stock or a value stockAchieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for MIRA Pharmaceuticals Inc.Free Capital Growth Strategies - Jammu Links News
Why is MIRA Pharmaceuticals Inc. stock attracting strong analyst attentionExplosive earning power - Jammu Links News
Does MIRA Pharmaceuticals Inc. stock perform well during market downturnsHigh-return market picks - Jammu Links News
What is MIRA Pharmaceuticals Inc. company’s growth strategyFinancial News Target Finder That Work - Jammu Links News
What are the technical indicators suggesting about MIRA Pharmaceuticals Inc.Advanced Screener Report With Low Risk - Jammu Links News
MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program - Sentinel-Standard
What catalysts could drive MIRA Pharmaceuticals Inc. stock higher in 2025Post Market Target Finder To Watch Now - Jammu Links News
How does MIRA Pharmaceuticals Inc. generate profit in a changing economyReal Time Planner For Fast Growth - Jammu Links News
Key External Factors That Drive MIRA Pharmaceuticals Inc. Stock Price MovementsGrowth Based Stock Signal Screener Updated - metal.it
How many analysts rate MIRA Pharmaceuticals Inc. as a “Buy”Best Dividend Report From AI Tools - Jammu Links News
Insider Sales At MIRA Pharmaceuticals Landed A Good Price - 富途牛牛
Revolutionary Topical Pain Drug Rivals Morphine in Efficacy: Major Breakthrough in $11.5B Market - Stock Titan
MIRA Pharmaceuticals Reports Promising Preclinical Results - TipRanks
Is This a Bottoming Phase for MIRA Pharmaceuticals Inc.Stock Market Entry Timing Signals Revealed - metal.it
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 - Investing.com Canada
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain - Corsicana Daily Sun
MIRA's Novel Pain Drug Shows 112% Better Relief Than Current Treatments, FDA Gives Green Light - Stock Titan
Mira Pharmaceuticals shares rise 2.91% after-hours following FDA clearance of Ketamir-2 IND. - AInvest
MIRA Pharmaceuticals Gets FDA Clearance for Ketamir-2 Trials - TipRanks
Mira Pharmaceuticals Inc (MIRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
1.44%
자본화:
|
볼륨(24시간):